Trial Profile
Clinical Trials Insight: 700015558
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2008
Price :
$35
*
At a glance
- Drugs Elafibranor (Primary)
- Indications Dyslipidaemias; Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Genfit
- 03 Oct 2006 New trial record.